J Korean Neuropsychiatr Assoc.  1998 Jan;37(1):186-193.

A Cabe of Clozapine-Induced Agranulocytosis

Affiliations
  • 1Department of Neuropsychiatry, Sanggye Paik Hospital, Inje University Medical College, Seoul, Korea.

Abstract

We report a 20-year-old female patient who developed clozapine-induced agranulocytosis on the 29th day of clozapine treatment. She recovered from the agranulocytosis on the 8th day of progression after treatment with G-CSE, GM-CSF, antibiotics and associated aseptic procedures. The cause of clozapine-induced agranulocytosis is still un known and it is proposed that the dominant gene of major histocompatibility complex region and the reactive metabolites which suppress the myeloid system may be responsible. We recommend that careful attentions such as the selection of patient, evaluation of the risk factors, and the thorough control of CPMS should be paid. If the agranulocytosis happens, it is helpful to consult to the department of medicine immediately.

Keyword

Clozapine; Agranulocytosis

MeSH Terms

Agranulocytosis*
Anti-Bacterial Agents
Attention
Clozapine
Female
Genes, Dominant
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Major Histocompatibility Complex
Risk Factors
United Nations
Young Adult
Anti-Bacterial Agents
Clozapine
Granulocyte-Macrophage Colony-Stimulating Factor
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr